Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$71.24 - $85.35 $378,711 - $453,720
5,316 New
5,316 $453,000
Q1 2023

May 12, 2023

BUY
$72.75 - $90.6 $445,448 - $554,743
6,123 New
6,123 $506,000
Q3 2018

Nov 07, 2018

SELL
$89.96 - $114.58 $449,799 - $572,900
-5,000 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$71.53 - $95.75 $357,650 - $478,750
5,000 New
5,000 $448,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.28B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.